Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT05038384
Other study ID # 2020-0792
Secondary ID NCI-2021-0892020
Status Withdrawn
Phase
First received
Last updated
Start date December 3, 2020
Est. completion date March 30, 2023

Study information

Verified date March 2023
Source M.D. Anderson Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study investigates the usefulness of the Self Care at Work Handbook in order to generate an improved version. Information from this study may help researchers identify potential factors associated with perception and usefulness of the Self Care at Work Handbook.


Description:

PRIMARY OBJECTIVES: I. To explore the global perception of the perceived usefulness of the handbook, and the frequency that the handbook is consulted. II. To explore the perceived usefulness of and adherence to each individual item of the handbook. III. To solicit personnel for their ideas about the handbook, and particularly any additional handbook items they might suggest. IV. To explore any relationships between the actual use or the perceived importance of each handbook item with respondents' self-reported professional satisfaction. V. To explore any associations between responses to handbook items and professional, demographic, and work satisfaction characteristics before and during the coronavirus disease 2019 (COVID-19) crisis. VI. To explore respondents' global perceptions of the usefulness and adherence to the handbook before and during the COVID-19 crisis. OUTLINE: Participants complete a survey over 20 minutes.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date March 30, 2023
Est. primary completion date March 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Clinicians in the Department of Palliative, Rehabilitation, and Integrative Medicine. This includes physicians, advanced practice providers (APPs), and other clinical staff in the Supportive Care Center and Acute Palliative Care Unit Exclusion Criteria: No

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survey Administration
Complete survey

Locations

Country Name City State
United States M D Anderson Cancer Center Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Global perception of usefulness Will be assessed by survey question E, which has five options: very useful, useful, neither useful nor useless, useless and very useless. The main interest is the proportion of responders who select very useful and useful. through study completion, an average of 1 year
Primary Frequency of consultation Will be assessed by survey question D, which has five options: never, once a month or less, a few times a month, a few times a week and daily. The main interest is the proportion of responders who select daily and a few times a week. through study completion, an average of 1 year
Primary Perceived usefulness of individual items Will be assessed by survey question F 1-9. Frequency and proportion will be used to summarize each item. For responders who select neither useful nor useless, useless and very useless, additional questions about whether one item should be retained, discarded or modified will be summarized using frequency and proportion. Comments or suggestions will be collected for qualitative analysis. through study completion, an average of 1 year
Primary Adherence to individual items Will be assessed by survey question G 1-9. Frequency and proportion will be used to summarize each item. For responders who select neither useful nor useless, useless and very useless, additional questions about whether one item should be retained, discarded or modified will be summarized using frequency and proportion. Comments or suggestions will be collected for qualitative analysis. through study completion, an average of 1 year
Primary Personal ideas about the handbook Will be collected by survey question I and question J. Comments and suggestions will be collected and used to aggregate opinions toward handbook improvement. through study completion, an average of 1 year
Primary Responders' self-reported professional satisfaction Will be assessed by survey question K, L1, and L3. Association between the perceived usefulness and professional satisfaction will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. Association between the adherence and professional satisfaction will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. through study completion, an average of 1 year
Primary Responders' profession Will be summarized by survey question A, and responders' demographics will be summarized by survey question B and C. Responders' work satisfaction after coronavirus disease 2019 (COVID-19) will be examined by survey question L2 and L4. Association between the perceived usefulness and responders' profession/demographics/work satisfaction after COVID-19 will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. Association between the adherence and responders' profession/demographics/work satisfaction after COVID-19 will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. through study completion, an average of 1 year
Primary Responders' global perceptions of usefulness and adherence to the handbook during COVID-19 Will be assessed by survey question M, N and O, and frequency and proportion will be used to summarize the results. through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT06030427 - Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Suspended NCT04060849 - Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY Phase 1
Recruiting NCT06192875 - A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)
Completed NCT04122118 - Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor N/A
Active, not recruiting NCT04940299 - Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma Phase 2
Active, not recruiting NCT03168737 - 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients Phase 1
Active, not recruiting NCT06062901 - An Educational Intervention on Provider Knowledge for the Support of Cancer Survivors N/A
Active, not recruiting NCT02444741 - Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer Phase 1/Phase 2
Terminated NCT04081298 - eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer Survivors N/A
Active, not recruiting NCT04555837 - Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer Phase 1/Phase 2
Completed NCT04983901 - PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN Phase 2
Active, not recruiting NCT04602026 - The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer N/A
Recruiting NCT04871542 - Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Recruiting NCT04592250 - Financial Toxicity in Cancer Patients
Recruiting NCT05112614 - Role of Gut Microbiome in Cancer Therapy
Active, not recruiting NCT04296305 - Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain Phase 4
Recruiting NCT05873608 - Communication Issues in Patient and Provider Discussions of Immunotherapy N/A
Recruiting NCT02464696 - Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure N/A
Recruiting NCT05372614 - Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene Phase 1

External Links